Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?
October 28, 2015|
The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.